Institutional Biosafety Committee (IBC)
Institutional Biosafety Committee (IBC) ensures that the research conducted at Mount Sinai that involves recombinant and synthetic nucleic acid molecules, biohazards, and potentially infectious materials complies with the NIH Guidelines, regardless of the source of funding. The IBC evaluates protocols involving human subjects or animals, and serves as a resource for obtaining information on how to conduct research activities in a safe manner.
Viviana Simon, MD, PhD
Policies & Manuals
Institutional Biosafety Committee Policies